Effects of evolocumab on plasma coenzyme Q10 in patients with heterozygous familial hypercholesterolemia
{{output}}
Background and aims: Muscle symptoms are common with statin therapy, and reduced plasma coenzyme Q10 (CoQ10) has been proposed as a potential mechanism. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are widely ... ...
